A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

Viatris

Status and phase: Completed; Phase 3

Conditions: Neuralgia

Treatments: Drug: Pregabalin (Lyrica)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00631943

A0081068

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of Lyrica in Indian patients with nerve pain

Enrollment: 112 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Peripheral neuropathic pain
• Score of at least 40 mm on the VAS of the SF-MPQ at screening and baseline
• Completion of at least 4 daily pain diary entries with an average daily pain score of at least 4 over the 7 days prior to baseline

Exclusion criteria

(none)

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

112 participants in 1 patient group

1

Experimental group

Treatment:

Drug: Pregabalin (Lyrica)